Psoriasis Concept

Vocabulary Service

MeSH

Overview

subject area of

2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009 Academic Article
A Psoriatic Patient-Based Survey on the Understanding of the Use of Vaccines While on Biologics During the COVID-19 Pandemic Academic Article
A Review of Drug-Drug Interactions for Biologic Drugs Used in the Treatment of Psoriasis Academic Article
A Useful Clinical Tool for Psoriasis Academic Article
A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial Academic Article
A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial* Academic Article
Acitretin Use in Dermatology Academic Article
Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet Academic Article
Adalimumab in the Treatment of Psoriasis: Pooled Efficacy and Safety Results from Three Pivotal Studies Academic Article
Adherence to guidelines in the use of biological agents to treat psoriasis in Brazil Academic Article
An Open Letter to Health Canada Academic Article
An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab. Academic Article
Bimekizumab: The First Dual Inhibitor of Interleukin (IL)-17A and IL-17F for the Treatment of Psoriatic Disease and Ankylosing Spondylitis Academic Article
Biologic survival. Academic Article
Biosimilars for psoriasis: clinical studies to determine similarity Academic Article
Biosimilars for psoriasis: preclinical analytical assessment to determine similarity Academic Article
Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice Academic Article
Briakinumab Academic Article
Brodalumab success in patients with moderate-to-severe psoriasis who failed previous interleukin-17A inhibitors Academic Article
Canadian Guidelines for the Management of Plaque Psoriasis: Overview Academic Article
Canadian Patients’ Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys Academic Article
Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi Study Academic Article
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway Academic Article
Clinical practice guidelines for psoriasis: which ones are the best? Academic Article
Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis Academic Article
Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis. Academic Article
Comparative study of histopathological and immunohistochemical findings in skin biopsies from patients with psoriasis before and after treatment with acitretin Academic Article
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials Academic Article
Cytokine-Based Therapy in Psoriasis Academic Article
Drug-Induced Lichenoid Dermatitis with Histopathologic Features of Mycosis Fungoides in a Patient with Psoriasis Academic Article
Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study Academic Article
Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis Academic Article
Efficacy Outcomes in Patients Using Alefacept in the AWARE Study Academic Article
Efficacy and Safety of Tripterygium wilfordii Hook F Versus Acitretin in Moderate to Severe Psoriasis Vulgaris Academic Article
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2) Academic Article
Etanercept Improves Quality of Life Outcomes and Treatment Satisfaction in Patients with Moderate to Severe Plaque Psoriasis in Clinical Practice Academic Article
Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab Academic Article
Granulocyte–macrophage colony‐stimulating factor ( GM ‐ CSF ) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐ GM ‐ CSF monoclonal antibody Academic Article
Immune Thrombocytopenia Associated with Efalizumab Therapy for Psoriasis Academic Article
Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use. Academic Article
Incidence and prognosis of COVID‐19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study Academic Article
Incidence and prognosis of COVID‐19 in psoriasis patients on biologic therapy: a multicentre retrospective cohort study Academic Article
Infliximab-Induced Psoriasis and Psoriasiform Skin Lesions in Pediatric Crohn Disease and a Potential Association With IL-23 Receptor Polymorphisms Academic Article
Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab Academic Article
Interleukin 17A: Toward a new understanding of psoriasis pathogenesis Academic Article
Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition Academic Article
Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper Academic Article
Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials Academic Article
Modular pharmacology-based approach to identify hub genes and kernel pathways of taodan granules treated psoriasis Academic Article
Mycophenolate Mofetil (CellCept�) for Psoriasis: A Two-Center, Prospective, Open-Label Clinical Trial Academic Article
Nail Psoriasis and Biologics Academic Article
Novel Loci, Including Those Related to Crohn Disease, Psoriasis, and Inflammation, Identified in a Genome-Wide Association Study of Fibrinogen in 17 686 Women Academic Article
Occurrence of Plantar Pustular Psoriasis during Treatment with Infliximab Academic Article
Off-Label High-Dose Secukinumab for the Treatment of Moderate-to-Severe Psoriasis Academic Article
Oncostatin M overexpression induces skin inflammation but is not required in the mouse model of imiquimod-induced psoriasis-like inflammation Academic Article
One-Year, Multicenter, Open-Label, Single-Arm Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Moderate-to-Severe Plaque Psoriasis in a Canadian Population Academic Article
Our Choice: study protocol for a randomized controlled trial for optimal implementation of psoriasis treatment by the integration of Chinese and western medicine Academic Article
Paradoxical, Cupping-Induced Localized Psoriasis: A Koebner Phenomenon Academic Article
Patient reports of the frequency and severity of adverse reactions associated with biological agents prescribed for psoriasis in Brazil Academic Article
Patient-Driven Discontinuation of Apremilast During the COVID-19 Pandemic in Two Canadian Academic Hospital Clinics and One Community Practice Academic Article
Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone Academic Article
Practical Understanding of Mean Percent Psoriasis Area and Severity Index Reduction for Biologics Academic Article
Psoriasis Is Associated With Elevated Gut IL-1α and Intestinal Microbiome Alterations Academic Article
Psoriasis in systemic lupus erythematosus: a single-center experience Academic Article
Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy Academic Article
Psoriasis patients’ preference for an aerosol foam topical formulation Academic Article
Psoronychomycosis Academic Article
Quality of life in plaque psoriasis patients treated with voclosporin: a Canadian phase III, randomized, multicenter, double-blind, placebo-controlled study Academic Article
Review and Practical Guidance on Managing Fungal Infections in Patients With Psoriasis Receiving Anti-IL-17 Therapies Academic Article
Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial Academic Article
Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE) Academic Article
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study Academic Article
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials Academic Article
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study Academic Article
Short-contact clobetasol propionate shampoo 0.05% improves quality of life in patients with scalp psoriasis. Academic Article
Skin erythema assessment techniques Academic Article
Survival of the fittest Academic Article
The Incidence and Prevalence of Uveitis in Psoriasis: A Systematic Review and Meta-Analysis Academic Article
The Role of Antimalarials in the Exacerbation of Psoriasis Academic Article
The Safety of Infliximab Infusions in the Community Setting Academic Article
Think beyond the Skin Academic Article
Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations Academic Article
Topical calcipotriol in childhood psoriasis Academic Article
Transitioning Between Brodalumab and Secukinumab in Moderate to Severe Psoriasis: An Early Look. Academic Article
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice Academic Article
Treatment of severe facial psoriasis with adalimumab. Academic Article
Trends in mortality and cause-specific mortality among patients with psoriasis and psoriatic arthritis in Ontario, Canada Academic Article
Trends in the Prevalence and Incidence of Psoriasis and Psoriatic Arthritis in Ontario, Canada: A Population‐Based Study Academic Article
Under-Reporting of COVID-19 Infections in Psoriasis Patients on Biologics Academic Article
Use of Calcipotriene Cream (Dovonex?? Cream) Following Acute Treatment of Psoriasis Vulgaris with the Calcipotriene/Betamethasone Dipropionate Two-Compound Product (Taclonex??) Academic Article
Water bath hyperthermia is a simple therapy for psoriasis and also stimulates skin tanning in response to sunlight Academic Article
Work Productivity and Healthcare Resource Utilization Outcomes for Patients on Etanercept for Moderate-to-Severe Plaque Psoriasis Academic Article